2762 Organometallics, Vol. 15, No. 12, 1996
Widenhoefer and Buchwald
2 H), 6.49 (d, J ) 7.5 Hz, 3 H), 3.28 (br s, 1 H, HN), 3.22 (d,
J ) 13 Hz, 2 H, R-CH2), 2.55 (d, J ) 13 Hz, 2 H, R-CH2), 2.26
[s, 9 H, P(o-tol)3], 2.08 (s, 3 H, C6H4Me), 1.60 (m, 3 H), 1.36
(m, 3 H). 31P{1H} NMR: δ 25.6. IR (Nujol): 3200 cm-1. Anal.
Calcd (found) for C33H39ClNPPd: C, 63.67 (63.46); H, 6.31
(6.53); N, 2.25 (2.39).
The procedure employed in the synthesis of 7 was applied
to the syntheses of complexes 8-16 and 18 by utilizing the
appropriate palladium aryl halide dimer and amine. All
complexes were isolated as cream or pale yellow powders;
yields are given in Table 1.
P d [P (o-tol)3](p-C6H4Me)(HNBu 2)Cl (8). 1H NMR: δ 7.75
(br s, 3 H), 7.28-7.11 (m, 9 H), 6.6 (br s, 2 H), 6.43 (d, J ) 7.7
Hz, 2 H), 3.55 (br s, 1 H, NH), 2.25 [br s, 9 H, P(o-tol)3], 2.06
(s, 3 H, C6H4Me), 1.80 (br s, 6 H), 1.30 (m, 6 H), 0.93 (t, J )
7.5 Hz, 6 H, -CH2CH3). 31P{1H} NMR: δ 27.4. IR (Nujol):
3215, 3200 cm-1. Anal. Calcd (found) for C36H47ClNPPd: C,
64.87 (65.01); H, 7.11 (7.30); N, 2.10 (2.15).
Hz, HNCH2Ph), 3.76 (br, 2 H, HNCH2Ph), 3.24 (br, 1 H, HN),
2.19 [s, 9 H, P(o-tol)3], 2.04 (s, 3 H, C6H4Me). 31P{1H} NMR:
δ 28.2. Anal. Calcd (found) for C42H43BrNPPd: C, 64.75
(64.74); H, 5.56 (5.55); N, 1.80 (1.80).
P d [P (o-tol)3](p-C6H4Me)[HN(i-P r )2]Cl (17). A solution of
1 (120 mg, 0.22 mmol) and diisopropylamine (770 mg, 7.6
mmol) in CH2Cl2 (3 mL) was stirred for 5 min at room
temperature. The yellow solution was concentrated to 1 mL
under vacuum, diluted with 5 mL of hexane, and cooled to -20
°C overnight. The resulting precipitate was collected, washed
with hexane, and dried under vacuum to give 17 (88 mg, 74%)
as yellow blocks. 1H NMR (CD2Cl2 [0.1 M HN(i-Pr)2], 25 °C;
17:1 ≈ 2:1): δ 2.05 (C6H4Me); additional resonances corre-
sponding to 17 were obscured by the resonances for 1 and free
HN(i-Pr)2. 31P{1H} NMR (CD2Cl2 [0.5 M HN(i-Pr)2], 25 °C):
δ 27.3. Anal. Calcd (found) for C34H43ClNPPd: C, 63.95
(64.05); H, 6.79 (6.63).
P d [P (o-tol)3](p-C6H4Me)[HN(i-P r )2]Br (19). Reaction of
diisopropylamine (1.4 g, 14 mmol) and 2 (100 mg, 0.17 mmol)
employing a procedure analogous to that used to prepare 17
led to the isolation of 19 (76 mg, 64%) as yellow crystals. 1H
NMR (CD2Cl2 [0.1 M HN(i-Pr)2], 25 °C; 19:2 ≈ 2:1): δ 2.05
(C6H4Me); additional resonances corresponding to 19 were
obscured by the resonances for 2 and free HN(i-Pr)2. 31P{1H}
NMR (CD2Cl2 [0.5 M HN(i-Pr)2], 25 °C): δ 26.6. Anal. Calcd
(found) for C34H43BrNPPd: C, 59.79 (59.77); H, 6.35 (6.21).
P d [P (o-tol)3](p-C6H4Me)(HNEt2)Cl (9). 1H NMR: δ 7.75
(br s, 3 H), 7.29 (t, J ) 7.4 Hz, 3 H), 7.12 (t, J ) 6.1 Hz, 6 H),
6.66 (br s, 2 H), 6.43 (d, J ) 7.7 Hz, 2 H), 3.40 (br s, 1 H, NH),
2.61 (br s, 2 H, NCH2CH3), 2.42 (m, 2 H, NCH2CH3), 2.26 [br
s, 9 H, P(o-tol)3], 2.06 (s, 3 H, C6H4Me), 1.44 (t, J ) 7.05, 6 H,
NCH2CH3). 31P{1H} NMR: δ 27.3. Anal. Calcd (found) for
C
32H39ClNPPd: C, 62.96 (62.77); H, 6.44 (6.28); N, 2.29 (2.22).
P d [P (o-t ol)3](p-C6H4Me)[HN(CH2)2O]Cl (10). 1H NMR
(20 °C): δ 7.30, 7.11, 6.45, 3.69 (br s, 1 H, HN), 3.64 (d, J )
11 Hz, 2 H, R-CH2), 3.40 (dt, J ) 2, 11 Hz, 2 H, R-CH2), 2.93
(br, 2 H, â-CH2), 2.65 (br, 2 H, â-CH2), 2.21 [s, 9 H, P(o-tol)3],
2.07 (s, 3 H, C6H4Me). 31P{1H} NMR: δ 25.9. IR (Nujol): 3174
P d [P (o-tol)3](p-C6H4Me)(HNBn 2)I (22). Dibenzylamine
(205 mg, 1.04 mmol) was added to an orange solution of 3 (56
mg, 0.09 mmol) in CH2Cl2 (5 mL), and the resulting yellow
solution was stirred for 5 min. Solvent was evaporated under
vacuum to give an orange oil, which was diluted with 5 mL of
hexane and cooled to -20 °C overnight. The resulting
precipitate was collected, washed with hexane (10 mL), and
dried under vacuum to give 22 (61 mg, 83%) as a yellow
microcrystalline solid. 1H NMR (CDCl3 (0.09 M HNBn2); 22:3
≈ 4:1): δ 6.31 (d, J ) 7.3 Hz), 6.10, 4.40 (br t, J ) 7 Hz) and
2.06 (s, C6H4Me); additional resonances corresponding to 22
were obscured by the resonances for free HNBn2 and 3. 31P-
{1H} NMR (CDCl3 (0.09 M HNBn2), 25 °C; 22:3 g 10:1): δ
28.0. Anal. Calcd (found) for C42H43INPPd: C, 61.07 (61.16);
H, 5.25 (5.44).
cm-1
. Anal. Calcd (found) for C32H37ClNOPPd: C, 61.55
(61.38); H, 5.97 (5.95); N, 2.24 (2.33).
P d [P (o-t ol)3](p-C6H 4Me)[HN(i-Bu )2]Cl (11). 1H NMR
(11:1 ≈ 12:1): δ 7.70 (br, 3 H), 7.29 (t, J ) 6.7 Hz, 3 H), 7.12
(br t, J ) 6.3 Hz, 6 H), 6.65 (br s, 2 H), 6.44 (d, J ) 7.6 Hz, 2
H), 3.65 (br, 1 H, NH), 2.24 [br s, 9 H, P(o-tol)3], 2.06 (s, 3 H,
C6H4Me), 0.94 [d, J ) 6.7 Hz, 6 H, NCH2CH(CH3)2], 0.86 [d, J
) 6.7 Hz, 6 H, NCH2CH(CH3)2]. 31P{1H} NMR (25 °C): δ 27.9.
Anal. Calcd (found) for C36H47ClNPPd: C, 64.87 (65.03); H,
7.11 (6.96); N, 2.10 (1.99).
P d [P (o-tol)3](p-C6H4Me)(HNBn 2)Cl (12). 1H NMR (20 °C;
12:1 > 20:1): δ 7.60 (br, 3 H), 7.32 (m, 13 H), 7.09 (m, 6 H),
6.31 (d, J ) 7.2 Hz, 2 H), 6.03 (br, 2 H), 4.35 (dd, 2 H, J ) 8.4,
13.8 Hz, HNCH2Ph), 3.70 (br, 2 H, HNCH2Ph), 3.20 (br, 1 H,
HN), 2.23 [s, 9 H, P(o-tol)3], 2.03 (s, 3 H, C6H4Me). 31P{1H}
The procedure employed in the synthesis of 22 was applied
to the syntheses of complexes 23-25, utilizing the appropriate
halide and amine; yields are given in Table 1.
NMR: δ 27.2. IR (Nujol): 3221 cm-1
. Anal. Calcd (found)
P d[P (o-tol)3](p-C6H4CMe3)(HNBn 2)I (23): orange needles.
1H NMR [CDCl3 (0.09 M HNBn2); 23:20 ≈ 15:1]: δ 6.55, 6.20,
4.42 (br, HNCH2Ph), 3.37, 1.14 (C6H4CMe3); additional reso-
nances corresponding to 23 were obscured by the resonances
for free HNBn2 and 20. 31P{1H} NMR (CDCl3 (0.09 M HNBn2),
25 °C): δ 28.3. Anal. Calcd (found) for C45H49INPPd: C, 62.26
(62.19); H, 5.69 (5.65).
for C42H43ClNPPd: C, 68.67 (68.55); H, 5.90 (6.11); N, 1.91
(2.01).
P d [P (o-tol)3](p-C6H4Me)[H2N(CH2)5Me]Cl (13). 1H NMR
(20 °C): 7.76 (m, 3 H), 7.30 (t, J ) 7 Hz, 3 H), 7.13 (m, 6 H),
6.63 (br s, 2 H), 6.47 (d, J ) 7.5 Hz, 2 H), 2.60 (br s, 2 H,
H2N), 2.56 (br s, 2 H, H2NCH2-), 2.21 [s, 9 H, P(o-tol)3], 2.07
(s, 3 H, C6H4Me), 1.40 (t, J ) 6 Hz, 2 H), 1.20 (t, J ) 7 Hz, 2
H), 1.11 (br s, 4 H), 0.80 [t, J ) 7.5 Hz, 3 H, H2N(CH2)5Me].
P d [P (o-tol)3](p-C6H4OMe)(HNBn 2)I (24): yellow powder.
1H NMR [CDCl3 (0.09 M HNBn2); 24:21 ≈ 15:1]: δ 6.24, 6.10,
4.43 (br, HNCH2Ph), 3.60 (s, C6H4OMe); additional resonances
corresponding to 24 were obscured by the resonances for free
HNBn2 and 21. 31P{1H} NMR (CDCl3 (0.09 M HNBn2), 25
°C): δ 28.1. Anal. Calcd (found) for C42H43INOPPd: C, 59.91
(59.66); H, 5.15 (5.35).
31P{1H} NMR: δ 25.8. Anal. Calcd (found) for C34H43
-
ClNPPd: C, 63.95 (64.11); H, 6.79 (6.75); N, 2.19 (2.21).
P d [P (o-tol)3](p-C6H4Me)(H2NCy)Cl (15). 1H NMR:
δ
7.76 (br, 3 H), 7.29 (t, 3 H, J ) 7.13 Hz), 7.10 (m, 6 H), 6.62
(m, 2 H), 6.46 (d, 2 H, J ) 7.46 Hz), 2.66, 2.47, 2.18 [br s, 9 H,
P(o-tol)3], 2.07 (s, 3 H, C6H4Me), 1.93 (d, J ) 9.06 Hz), 1.60
(m), 1.46 (m), 1.05 (m). 31P{1H} NMR: δ 27.9. Anal. Calcd
(found) for C34H41ClNPPd: C, 64.16 (63.97); H, 6.49 (6.50); N,
2.20 (2.18).
P d [P (o-t ol)3](p-C6H4Me)(H2N-t-oct yl)Cl (16). 1H NMR
(16:1 ≈ 8:1): δ 7.70 (br, 3 H), 7.28 (t, 6 H, J ) 6.04 Hz), 7.24
(m, 3 H), 6.65 (m, 2 H), 6.42 (d, 2 H, J ) 6.49 Hz), 3.14 (br, 2
H, H2N-t-octyl), 2.18 [br s, 9 H, P(o-tol)3], 2.07 (s, 3 H, C6H4Me),
1.09 (m). 31P{1H} NMR: δ 30.0. Anal. Calcd (found) for
P d [P (o-tol)3](p-C6H4OMe)(H2NCMe2CH2CMe3)I (25): or-
ange crystals. 1H NMR (CDCl3 (0.09 M tert-octylamine), 25:
21 ≈ 15:1): δ 3.63 (s, C6H4OMe); additional resonances
corresponding to 25 were obscured by the resonances for free
tert-octylamine and 21. 31P{1H} NMR (CDCl3 (0.09 M tert-
octylamine), 25 °C): δ 28.3. Anal. Calcd (found) for C36H47
-
INOPPd: C, 55.86 (55.60); H, 6.12 (6.35).
P d [P (o-t ol)3](p-C6H4Me)[HN(i-P r )2]I (26). Complex 26
was generated by addition of diisopropylamine to a solution
of 3 in CD2Cl2 and was analyzed without isolation. 1H NMR
(300 MHz, CD2Cl2 [0.5 M HN(i-Pr)2], 25 °C; 26:3 ≈ 1:2): δ 2.05
(C6H4Me); additional resonances corresponding to 26 were
C
36H47ClNPPd: C, 64.87 (64.82); H, 7.11 (7.28); N, 2.10 (2.00).
P d [P (o-tol)3](p-C6H4Me)(HNBn 2)Br (18). 1H NMR (20
°C; 18:2 ≈ 20:1): δ 7.38-7.27 (13 H), 7.12-7.01 (6 H), 6.31
(d, J ) 7.8 Hz, 2 H), 6.05 (br, 2 H), 4.38 (dd, 2 H, J ) 7.7, 12.2